Agios Pharmaceuticals, Inc.
AGIO
$27.42
-$0.07-0.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -159.51% | 278.14% | 288.87% | 291.35% | 407.03% |
| Total Depreciation and Amortization | -7.22% | -12.03% | -9.67% | -14.65% | -19.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.84% | -1,610.41% | -1,638.81% | -1,632.94% | -1,531.80% |
| Change in Net Operating Assets | -332.80% | -82.49% | -22.55% | -3.73% | 340.60% |
| Cash from Operations | -24.54% | -32.43% | -33.49% | -31.68% | -13.61% |
| Capital Expenditure | -337.29% | -235.59% | -211.74% | -68.67% | -8.43% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -100.00% | -96.98% | -98.25% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | -21.65% | -33.79% | -49.76% | -31.00% | 36.98% |
| Cash from Investing | -53.17% | 32.54% | 14.66% | 51.70% | 123.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.92% | -5.46% | 15.48% | 165.82% | 122.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.92% | -5.46% | 15.48% | 165.82% | 126.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.02% | -1,451.91% | -372.14% | 76.58% | 425.89% |